Suppr超能文献

纤维蛋白鞘及其与隧道式透析导管更换后后续事件的关系。

Fibrin sheath and its relation to subsequent events after tunneled dialysis catheter exchange.

作者信息

Shanaah Almothana, Brier Michael, Dwyer Amy

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine and Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OhioUniversity of Louisville and Robley Rex VA Medical Center, Louisville, KentuckyUniversity of Louisville, Louisville, Kentucky.

出版信息

Semin Dial. 2013 Nov-Dec;26(6):733-7. doi: 10.1111/sdi.12074. Epub 2013 Feb 27.

Abstract

The use of tunneled catheters (TDC) for chronic hemodialysis is frequent and often fails due to fibrin or thrombus and infection. We hypothesized that the presence of fibrin sheath in TDC increases the risk for subsequent catheter malfunction and infection. We did a retrospective review of TDC exchanges and de novo placements from January 2005 to September 2011. Demographic data, information about the catheter procedure, and radiological data were collected. Final outcome analysis included 168 procedure events. Three groups of catheter procedures were identified: catheter exchange without a fibrin sheath (CE), catheter exchange with a treated fibrin sheath (CEF), and de novo catheter placements (DCP). Fibrin sheath incidence was 47%. In the CEF group, there was no statistical difference in the incidence of subsequent infections or dysfunctions (7% and 60%, respectively), when compared with the CE group (9% and 43%, respectively), (p=0.3). Mean time to subsequent dysfunction or infection was similar for CEF and CE (135 vs. 136 days, p-value, 0.98). Fibrin sheaths are common and should be evaluated when performing TDC exchange. If the fibrin sheath is treated, there is no increased incidence in subsequent catheter dysfunction or infection compared with patients without a fibrin sheath.

摘要

长期血液透析使用带隧道的导管(TDC)很常见,但常因纤维蛋白或血栓以及感染而失败。我们推测TDC中纤维蛋白鞘的存在会增加随后导管功能障碍和感染的风险。我们对2005年1月至2011年9月期间的TDC更换和初次置管进行了回顾性研究。收集了人口统计学数据、导管操作信息和放射学数据。最终结局分析包括168例操作事件。确定了三组导管操作:无纤维蛋白鞘的导管更换(CE)、有经处理纤维蛋白鞘的导管更换(CEF)和初次导管置管(DCP)。纤维蛋白鞘发生率为47%。与CE组(分别为9%和43%)相比,CEF组随后感染或功能障碍的发生率(分别为7%和60%)无统计学差异(p=0.3)。CEF组和CE组至随后功能障碍或感染的平均时间相似(135天对136天,p值为0.98)。纤维蛋白鞘很常见,在进行TDC更换时应进行评估。如果纤维蛋白鞘得到处理,与没有纤维蛋白鞘的患者相比,随后导管功能障碍或感染的发生率不会增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验